What You Should Know
- Los Angeles-based health system Cedars-Sinai has deployed OpenEvidence systemwide, giving its entire enterprise care team access to an AI-enabled clinical reference tool directly integrated within the Electronic Health Record (EHR).
- The AI platform functions at the point of care by dynamically linking the latest peer-reviewed medical literature and scientific findings with an individual patient’s unique history, including comorbidities, prior procedures, medications, allergies, and lab data.
- To enhance institutional consistency, Cedars-Sinai plans to incorporate its own proprietary care pathways, operational protocols, and best practices directly into the OpenEvidence enterprise workspace.
- Addressing data protection parameters, patient information pulled from the EHR is utilized strictly to contextualize immediate clinical decision support and is never permanently stored by OpenEvidence or used for foundational model training.
- To prevent uncalibrated deployments, Cedars-Sinai enforces a rigorous governance model where a specialized committee of data scientists, clinical experts, and administrative leaders reviews and audits all AI systems before they go live.
Cedars-Sinai Deploys OpenEvidence Enterprise Platform to Drive Precision Clinical Decision Support
The rapid maturation of healthcare artificial intelligence has pushed the industry past a critical milestone. For several years, health systems treated generative AI primarily as an experimental novelty or restricted it to isolated administrative pilots. In 2026, the axis of competition has decisively shifted toward integrated point-of-care infrastructure. Leading hospital networks are no longer asking how AI works in theory; they are implementing specialized “systems of action” designed to alter clinical decision-making in real time.
A primary challenge facing frontline clinicians has long been the sheer volume and abstraction of medical data. Reviewing thousands of newly published peer-reviewed journal articles, updated federal guidelines, and clinical trial results is a massive task. Furthermore, traditional search tools operate in a vacuum—returning generalized medical evidence that forces the provider to manually map the text against the intricate realities of the patient sitting in front of them.
To bridge this operational disconnect and bring clinical-grade evidence directly to the bedside, Los Angeles-based Cedars-Sinai has announced the systemwide deployment of OpenEvidence. Integrated directly into the organization’s electronic health record (EHR) architecture, the enterprise platform provides a unified workspace where physicians, nurses, pharmacists, and therapists can instantly surface patient-contextual medical literature using standard natural language queries.
Moving Past Abstract Information to Patient-Specific Insights
The strategic alliance establishes a new standard for how clinical decision support (CDS) software interacts with human workflows. Rather than requiring clinicians to switch tabs or open separate reference software, OpenEvidence automatically evaluates the active EHR view to interpret global medical knowledge in the exact context of the specific patient’s medical history.
When a care team member submits a clinical query, the tool dynamically references the patient’s longitudinal data, including:
- Historical and current clinical diagnoses
- Documented comorbidities and multi-system complexities
- Active pharmaceutical regimens, past procedures, and recorded allergies.
Shaun Miller, MD, MBA, chief health informatics officer at Cedars-Sinai, noted that integrating the tool into core records allows healthcare professionals to view the latest peer-reviewed science through the lens of individual health data, delivering a more complete and actionable clinical understanding at the precise moment of care.
Crucially, this data mobility does not expand the hospital’s cybersecurity threat exposure. To maintain absolute data privacy and comply with rigid intellectual property protections, any patient information extracted from the EHR is used solely to contextualize the active session. OpenEvidence does not store, retain, or ingest patient records, ensuring a highly secure environment for protected health information (PHI).
Unifying Global Evidence with Local Care Pathways
To prevent clinical drift and maximize institutional alignment, Cedars-Sinai is leveraging OpenEvidence’s enterprise customization capabilities. The health system plans to systematically ingest its own internal care pathways, localized safety protocols, and clinical best practices directly into the AI platform’s underlying knowledge layer.
This means that when a clinician queries a complex therapeutic approach, the interface will surface current international medical literature side-by-side with Cedars-Sinai-specific guidance. This dual-layer approach provides a highly standardized regulatory safety net, ensuring that care delivered across all departments meets the exact quality benchmarks defined by institutional leadership.
This systemwide deployment represents just one component of Cedars-Sinai’s broader, coordinated AI strategy. The organization is actively deploying specialized machine learning applications to streamline real-time documentation for nursing staff, automate complex reports generated from echocardiograms, and utilize predictive data modeling to determine optimal chemotherapy selection for pancreatic cancer patients.
